Article
N-RAS mutations and susceptibility to lymphokine-activated killer (LAK) cells in human melanoma.
Melanoma research - 1 Feb 1994
Lupetti R, Sensi M, Mortarini R, Anichini A, Clemente C, Parmiani G
Abstract excerpt
RAS oncogene expression has been reported to affect several biological features of rodent tumours cells, including lysability by activated natural killer cells. In order to examine whether expression of mutated RAS genes in human melanoma cells alters their susceptibility to lysis by LAK cells, seven melanoma lines were assessed for the presence of Ki- and N-RAS genes bearing all possible mutations at codons 12,...
Topics
- Base Sequence
- Clone Cells
- Gene Expression Regulation, Neoplastic
- Genes, ras
- Humans
- Immunotherapy, Adoptive
- Killer Cells, Lymphokine-Activated
- Lymphocyte Activation
- Melanoma
- Molecular Sequence Data
- Mutation
